Global HPV Vaccine for Men(Male HPV Vaccine) Market Research Report 2024

Publication ID:

PB512243241

Publication Date:

December 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for HPV Vaccine for Men(Male HPV Vaccine) was valued at US$ 21 million in the year 2023 and is projected to reach a revised size of US$ 33.2 million by 2030, growing at a CAGR of 7.1% during the forecast period.
Male HPV vaccine refers to the HPV vaccine developed specifically for men. HPV (human papillomavirus) is a virus that can infect the skin and mucous membranes, and is divided into low-risk and high-risk types. Low-risk HPV infection may cause skin lesions such as genital warts, while high-risk HPV infection is associated with an increased risk of malignant tumors such as penile cancer, anal cancer, and oral cancer. Therefore, HPV vaccination for men is of great significance in preventing these diseases, which can not only prevent related diseases but also reduce the risk of transmission.
North American market for HPV Vaccine for Men(Male HPV Vaccine) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HPV Vaccine for Men(Male HPV Vaccine) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of HPV Vaccine for Men(Male HPV Vaccine) include Merck, Wantai Biotech, Kangle Guardian, Bovaxbio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HPV Vaccine for Men(Male HPV Vaccine), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Vaccine for Men(Male HPV Vaccine).
The HPV Vaccine for Men(Male HPV Vaccine) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HPV Vaccine for Men(Male HPV Vaccine) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HPV Vaccine for Men(Male HPV Vaccine) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Wantai Biotech
Kangle Guardian
Bovaxbio
by Type
Domestic
Imported
by Application
Genital Warts
Penile Cancer and Precancerous Lesions
Perineal Cancer and Precancerous Lesions
Perianal Cancer and Precancerous Lesions
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HPV Vaccine for Men(Male HPV Vaccine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HPV Vaccine for Men(Male HPV Vaccine) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 HPV Vaccine for Men(Male HPV Vaccine) Market Overview
1.1 Product Definition
1.2 HPV Vaccine for Men(Male HPV Vaccine) by Type
1.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Value Comparison by Type (2024-2030)
1.2.2 Domestic
1.2.3 Imported
1.3 HPV Vaccine for Men(Male HPV Vaccine) by Application
1.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Application (2024-2030)
1.3.2 Genital Warts
1.3.3 Penile Cancer and Precancerous Lesions
1.3.4 Perineal Cancer and Precancerous Lesions
1.3.5 Perianal Cancer and Precancerous Lesions
1.3.6 Others
1.4 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size Estimates and Forecasts
1.4.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue 2019-2030
1.4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales 2019-2030
1.4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HPV Vaccine for Men(Male HPV Vaccine) Market Competition by Manufacturers
2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Manufacturers (2019-2024)
2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of HPV Vaccine for Men(Male HPV Vaccine), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Product Type & Application
2.7 Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Date of Enter into This Industry
2.8 Global HPV Vaccine for Men(Male HPV Vaccine) Market Competitive Situation and Trends
2.8.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HPV Vaccine for Men(Male HPV Vaccine) Players Market Share by Revenue
2.8.3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Scenario by Region
3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2019-2030
3.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2019-2024
3.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2025-2030
3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2019-2030
3.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2019-2024
3.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2025-2030
3.4 North America HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country
3.4.1 North America HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2019-2030)
3.4.3 North America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country
3.5.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2019-2030)
3.5.3 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Region
3.6.1 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2019-2030)
3.6.3 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country
3.7.1 Latin America HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2019-2030)
3.7.3 Latin America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country
3.8.1 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2019-2030)
3.8.3 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2019-2030)
4.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2019-2024)
4.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2025-2030)
4.1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2019-2030)
4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2019-2030)
4.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2019-2024)
4.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2025-2030)
4.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2019-2030)
4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Price by Type (2019-2030)
5 Segment by Application
5.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2019-2030)
5.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2019-2024)
5.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2025-2030)
5.1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2019-2030)
5.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2019-2030)
5.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2019-2024)
5.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2025-2030)
5.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2019-2030)
5.3 Global HPV Vaccine for Men(Male HPV Vaccine) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Wantai Biotech
6.2.1 Wantai Biotech Company Information
6.2.2 Wantai Biotech Description and Business Overview
6.2.3 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
6.2.5 Wantai Biotech Recent Developments/Updates
6.3 Kangle Guardian
6.3.1 Kangle Guardian Company Information
6.3.2 Kangle Guardian Description and Business Overview
6.3.3 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
6.3.5 Kangle Guardian Recent Developments/Updates
6.4 Bovaxbio
6.4.1 Bovaxbio Company Information
6.4.2 Bovaxbio Description and Business Overview
6.4.3 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio
6.4.5 Bovaxbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Chain Analysis
7.2 HPV Vaccine for Men(Male HPV Vaccine) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HPV Vaccine for Men(Male HPV Vaccine) Production Mode & Process
7.4 HPV Vaccine for Men(Male HPV Vaccine) Sales and Marketing
7.4.1 HPV Vaccine for Men(Male HPV Vaccine) Sales Channels
7.4.2 HPV Vaccine for Men(Male HPV Vaccine) Distributors
7.5 HPV Vaccine for Men(Male HPV Vaccine) Customers
8 HPV Vaccine for Men(Male HPV Vaccine) Market Dynamics
8.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Trends
8.2 HPV Vaccine for Men(Male HPV Vaccine) Market Drivers
8.3 HPV Vaccine for Men(Male HPV Vaccine) Market Challenges
8.4 HPV Vaccine for Men(Male HPV Vaccine) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
Wantai Biotech
Kangle Guardian
Bovaxbio

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂